Annual ROA
17.43%
+65.33%+136.39%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual return on assets is 17.43%, with the most recent change of +65.33% (+136.39%) on December 31, 2023.
- During the last 3 years, CTNM annual ROA has risen by +58.56% (+142.38%).
- CTNM annual ROA is now at all-time high.
Performance
CTNM ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-20.52%
-0.05%-0.24%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly return on assets is -20.52%, with the most recent change of -0.05% (-0.24%) on September 30, 2024.
- Over the past year, CTNM quarterly ROA has dropped by -37.39% (-221.64%).
- CTNM quarterly ROA is now -135.55% below its all-time high of 57.72%, reached on June 1, 2023.
Performance
CTNM Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
CTNM ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +136.4% | -221.6% |
| 3 y3 years | +142.4% | -38.3% |
| 5 y5 years | +142.4% | -38.3% |
CTNM ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +136.4% | -135.6% | +15.8% |
| 5 y | 5-year | at high | +136.4% | -135.6% | +15.8% |
| alltime | all time | at high | +136.4% | -135.6% | +15.8% |
Contineum Therapeutics Class A ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -20.52%(+0.2%) |
| Jun 2024 | - | -20.47%(-240.2%) |
| Mar 2024 | - | 14.60%(-13.5%) |
| Dec 2023 | 17.43% | 16.87%(-30.4%) |
| Sep 2023 | - | 24.23%(-58.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 57.72%(-336.9%) |
| Mar 2023 | - | -24.36%(+64.2%) |
| Dec 2022 | -47.90%(+16.5%) | - |
| Dec 2022 | - | -14.84% |
| Dec 2021 | -41.13% | - |
FAQ
- What is Contineum Therapeutics Class A annual return on assets?
- What is the all time high annual ROA for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual ROA year-on-year change?
- What is Contineum Therapeutics Class A quarterly return on assets?
- What is the all time high quarterly ROA for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly ROA year-on-year change?
What is Contineum Therapeutics Class A annual return on assets?
The current annual ROA of CTNM is 17.43%
What is the all time high annual ROA for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual return on assets is 17.43%
What is Contineum Therapeutics Class A annual ROA year-on-year change?
Over the past year, CTNM annual return on assets has changed by +65.33% (+136.39%)
What is Contineum Therapeutics Class A quarterly return on assets?
The current quarterly ROA of CTNM is -20.52%
What is the all time high quarterly ROA for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly return on assets is 57.72%
What is Contineum Therapeutics Class A quarterly ROA year-on-year change?
Over the past year, CTNM quarterly return on assets has changed by -37.39% (-221.64%)